[The use of augmentin (amoxicillin/clavulanate) in the postoperative period in patients with infectious-inflammatory diseases of the ENT organs].
Augmentin (SmithKline Beecham) was used in the treatment of 24 patients after operations on the otorhinolaryngologic organs. The drug was administered orally, intravenously or applied locally. After a radical operation on the maxillary sinus the use of augmentin resulted in a marked decrease of the wound secretion and soft tissue edema on the 6th-7th days. After tonsillectomy cleaning of the tonsil niche from the fibrin patches and the epithelialization started on the 4th-5th days. After operations on the temporal bone cleaning of the postoperative cavity and beginning of the epithelialization were observed on the 9th-10th days. On the whole, the use of augmentin accelerated the cure which was recorded 3-4 days earlier.
Luchsheva
Iu V
IuV
Moscow Research Institute of Otorhinolaryngology, Ministry of Public Health of the Russian Federation.
Kriukov
A I
AI
Petrovskaia
A N
AN
D000293:Adolescent; D000328:Adult; D019980:Amoxicillin-Potassium Clavulanate Combination / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007239:Infections / Q000188:drug therapy / Q000601:surgery; D007249:Inflammation / Q000188:drug therapy / Q000601:surgery; D008297:Male; D008875:Middle Aged; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy* / Q000601:surgery; D011182:Postoperative Care; D013997:Time Factors
D000900:Anti-Bacterial Agents; D019980:Amoxicillin-Potassium Clavulanate Combination